Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 52Brain Neoplasms 51Carcinoma, Non-Small-Cell Lung 48Neoplasm Metastasis 30Lung Neoplasms 29Breast Neoplasms 23Pancreatic Neoplasms 16Melanoma 15Carcinoma, Renal Cell 14Carcinoma, Hepatocellular 13Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Urinary Bladder Neoplasms 7Small Cell Lung Carcinoma 7Colorectal Neoplasms 7Kidney Neoplasms 5Liver Neoplasms 4Glioblastoma 4Uveal Melanoma 3Triple Negative Breast Neoplasms 3Spinal Cord Neoplasms 3Sarcoma 3Prostate Cancer Metastatic 3NSCLC 3Meningioma 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Carcinoma, Transitional Cell 3Adenocarcinoma 3

Interventions

etoposide phosphate 1elacestrant 1binimetinib 1abemaciclib 1XENP 1595 1Tissue Banks 1Radiosurgery 1RAD1901 1PF-07284890 1Midazolam 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Diseases × Radiosurgery × 1 year × Clear all
NCT05270707 2025-09-24

HyperArc Registry Study

Varian, a Siemens Healthineers Company

Completed
968 enrolled
CNS

Brain Diseases, Brain Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡